Bringing the fundamentals into focus…
Back to Fortrea Holdings Inc.
How Fortrea Holdings Inc. stacks up
FTRE · against 406 other Healthcare companies of similar size
Valuation
38/ 100
Below the middle of the pack.
Ranked #264 of 407 · scores higher than 34% of peers
Bars: peers in each 10-point band of the valuation score32 peers with a valuation score of 30–39, including FTRE · Click a bar to see the companies
Why valuation scores 38?
Weighted metrics compared with all Healthcare companies.Mainly because of its earnings yield, which is weaker than most Healthcare peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -4.4% vs peer median 1.5%
- EBITDA yield is close to the peer norm. EBITDA yield: 2.3% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 93% of peers. Free cash flow yield: 9.8% vs peer median 0.0%
Metric by metric
Position: dot = FTRE, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | FTRE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 395 reported | -4.3% | 1.7% | 25% | 30% | |
| EBITDA yieldHigher is better · 407 reported | 3.3% | 4.5% | 45% | 50% | |
| Free cash flow yieldHigher is better · 191 reported | 9.8% | -0.5% | 91% | 20% | |
| Book yieldHigher is better · 398 reported | 26.3% | 34.9% | 37% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around FTREScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score